Prophylaxis of thromboembolic events in surgery: DVT prophylaxis: A comparison of out-patient and hospitalized patients;Prophylaxe thromboembolischer Ereignisse in der Chirurgie: TVT-Prophylaxe: Vergleich ambulant vs. stationär

Unfallchirurg

Volumn 116, Issue 3, 2013, Pages 246-254

  Fecher, K ^a   Ewald, W ^b   Furst A ^c   Hohmann, V ^d   Bramlage, P ^e  

^a Zentrum für Fußchirurgie   (Germany)

^b UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^c CARITAS KRANKENHAUS ST JOSEF   (Germany)

^d SANOFI AVENTIS DEUTSCHLAND GMBH   (Germany)

^e Institut für Kardiovaskuläre Pharmakologie und Epidemiologie   (Germany)

Author keywords

Anticoagulation; Bleeding; Enoxaparin; Low molecular weight heparins; Pulmonary embolism

Indexed keywords

ENOXAPARIN; FIBRINOLYTIC AGENT;

AMBULATORY CARE; ARTICLE; COMORBIDITY; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; GERMANY; HOSPITAL PATIENT; HOSPITALIZATION; HUMAN; MALE; MIDDLE AGED; OUTPATIENT; POSTOPERATIVE COMPLICATION; PREVALENCE; RISK ASSESSMENT; STATISTICS; TREATMENT OUTCOME; VEIN THROMBOSIS; POSTOPERATIVE COMPLICATIONS; STATISTICS AND NUMERICAL DATA; VENOUS THROMBOSIS;

AMBULATORY CARE; COMORBIDITY; ENOXAPARIN; FEMALE; FIBRINOLYTIC AGENTS; GERMANY; HOSPITALIZATION; HUMANS; INPATIENTS; MALE; MIDDLE AGED; OUTPATIENTS; POSTOPERATIVE COMPLICATIONS; PREVALENCE; RISK ASSESSMENT; TREATMENT OUTCOME; VENOUS THROMBOSIS;

EID: 84879899278     PISSN: 01775537     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00113-011-2094-7     Document Type: Article

References (21)

1. AWMF (2010) S3-Leitlinie: Prophylaxe der venösen Thromboembolie (VTE). http://www.uni-duesseldorf.de/AWMF/ll/003-001l.pdf
2. Geerts WH, Bergqvist D, Pineo GF et al (2008) Prevention of venous thromboembolism: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest 133:381S-453S (Pubitemid 351894916)
3. Mismetti P, Laporte S, Darmon JY et al (2001) Meta-analysis of low molecular weight heparin in the prevention of venous thromboembolism in general surgery. Br J Surg 88:913-930 (Pubitemid 34015572)
4. Bergqvist D (2004) Low molecular weight heparin for the prevention of venous thromboembolism after abdominal surgery. Br J Surg 91:965-974 (Pubitemid 39070809)
5. ENOXACAN Study Group (1997) Efficacy and safety of enoxaparin versus unfractionated heparin for prevention of deep vein thrombosis in elective cancer surgery: a double-blind randomized multicentre trial with venographic assessment. Br J Surg 84:1099-1103
6. Koch A, Bouges S, Ziegler S et al (1997) Low molecular weight heparin and unfractionated heparin in thrombosis prophylaxis after major surgical intervention: update of previous meta-analyses. Br J Surg 84:750-759 (Pubitemid 27235250)
7. Enoch S, Woon E, Blair SD (2003) Thromboprophylaxis can be omitted in selected patients undergoing varicose vein surgery and hernia repair. Br J Surg 90:818-820 (Pubitemid 36886382)
8. Riber C, Alstrup N, Nymann T et al (1996) Postoperative thromboembolism after day-case herniorrhaphy. Br J Surg 83:420-421 (Pubitemid 26083188)
9. Haas S (2004) Prevention of deep vein thrombosis in surgical departments. Chirurg 75:323-342
10. NICE (2007) Venous thromboembolism: Reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in inpatients undergoing surgery. NICE, London
11. Hull RD, Pineo GF (1999) Extended prophylaxis against venous thromboembolism following total hip and knee replacement. Haemostasis 29(Suppl 1):23-31 (Pubitemid 30026738)
12. Hoppener MR, Ettema HB, Henny CP et al (2006) Low incidence of deep vein thrombosis after knee arthroscopy without thromboprophylaxis: a prospective cohort study of 335 patients. Acta Orthop 77:767-771 (Pubitemid 44521917)
13. Engbaek J, Bartholdy J, Hjortso NC (2006) Return hospital visits and morbidity within 60 days after day surgery: a retrospective study of 18,736 day surgical procedures. Acta Anaesthesiol Scand 50:911-919 (Pubitemid 44272712)
14. Michot M, Conen D, Holtz D et al (2002) Prevention of deep-vein thrombosis in ambulatory arthroscopic knee surgery: A randomized trial of prophylaxis with low - molecular weight heparin. Arthroscopy 18:257-263 (Pubitemid 36114580)
15. Wasowicz-Kemps DK, Biesma DH, Schagen van Leeuwen J, Van Ramshorst B (2006) Prophylaxis of venous thromboembolism in general and gynecologic day surgery in The Netherlands. J Thromb Haemost 4:269-271
16. Kearon C (2001) Epidemiology of venous thromboembolism. Semin Vasc Med 1:7-26
17. Demers C, Marcoux S, Ginsberg JS et al (1998) Incidence of venographically proved deep vein thrombosis after knee arthroscopy. Arch Intern Med 158:47-50 (Pubitemid 28070445)
18. Friebe H, Peters A (2006) Clexane in arthroscopic surgery - CLASS. primary prevention of thromboembolic events in arthroscopic surgery at the knee - a multicenter postmarketing survey. Akt Traumatol 36:166-170 (Pubitemid 44544947)
19. Haas S, Hohmann V, Bramlage P (2010) Prevention of venous thromboembolism using enoxaparin in day surgery: Results of the SMART non-interventional study. Acta Orthop Scand submitted
20. Eriksson BI, Kakkar AK, Turpie AG et al (2009) Oral rivaroxaban for the prevention of symptomatic venous thromboembolism after elective hip and knee replacement. J Bone Joint Surg Br 91:636-644
21. Delis KT, Hunt N, Strachan RK, Nicolaides AN (2001) Incidence, natural history and risk factors of deep vein thrombosis in elective knee arthroscopy. Thromb Haemost 86:817-821. (Pubitemid 32834191)